Issuing Body Health Canada
Issuing Body Country CA - Canada
Issuing Body Website https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html
Located in Mississauga, Ontario, Eurofins CDMO Alphora delivers comprehensive solutions for small molecule & biologic drug substance and drug product all under one roof. Our small molecule capabilities include the development and manufacture of APIs and HPAPIs, oral drug products and API solid-state R&D. Our biologics capabilities include the development and manufacture of mAbs, proteins and ADC's, and Sterile Fill (2026). With over 250 skilled professionals, a facility inspected by the FDA, Health Canada, and Japans PMDA, we've been a trusted partner since 2003. Our integrated services span pre-clinical, to commercial stages accelerating timelines and ensuring quality at every step.
2884 Portland Drive, 2892 Portland Drive, Oakville L6H 5W8, Canada
Laboratory+1 905 403 0477
Issuing Body Health Canada
Issuing Body Country CA - Canada
Issuing Body Website https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html
Issuing Body Health Canada
Issuing Body Country CA - Canada
Issuing Body Website https://www.drug-inspections.canada.ca/gmp/index-en.html
Drug development and manufacturing for biologics and small molecules, with integrated services from preclinical to commercialisation.
Eurofins CDMO Alphora is a Canadian contract drug development and manufacturing organisation which delivers fully integrated process development and GMP manufacturing solutions for small molecule and biologic drug substances and drug products under one roof. Our capabilities cut across complex and highly potent APIs, oral drug products, monoclonal antibodies (mAbs), Antibody Drug Conjugates (ADCs), and therapeutic proteins.
Established in 2003, our FDA, Health Canada, and Japan PMDA inspected sites also provide advanced analytical services including Solid-State R&D, supporting biopharmaceutical companies from preclinical to clinical and commercialisation.
Our sites are strategically located on a 14-acre campus in Ontario, Canada.
Home Site
2240 Speakman Drive
Mississauga, ON L5K 1A9
Canada
Hadwen Site
2070 Hadwen Road
Mississauga, ON L5K 2C9
Canada
Portland Sites
2884 & 2892 Portland Drive
Oakville, ON L6H 5W8
Canada
We provide scientific expertise and cutting-edge technologies in the following areas, all under one roof.
Small Molecule API
Drug Product
Highly Potent API (HPAPI)
Solid State Research and Development (SSRD)
Biologics (mAbs)
Antibody Drug Conjugates (ADCs)